End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
785,000 KRW | +1.82% | +0.51% | +3.29% |
05-06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.29% | 40.44B | |
-2.56% | 88.14B | |
-15.40% | 32.24B | |
+51.96% | 24.39B | |
-14.35% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.41% | 12.14B | |
+5.17% | 8.87B | |
-7.13% | 8.41B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics to Produce AstraZeneca's COVID-19 Antibody Combination AZD7442